View in EDS

Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.

Saved in:
Bibliographic Details
Title: Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
Authors: Qian K; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Tang CY; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Changxing People's Hospital of Zhejiang, Huzhou 313100, China., Chen LY; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Zheng S; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Zhao Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Ma LS; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China., Xu L; The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China., Fan LH; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Yu JD; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Tan HS; Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Sun YL; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Shen LL; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Lu Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China., Liu Q; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States., Liu Y; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill 27599, North Carolina, United States., Xiong Y; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Source: ACS omega [ACS Omega] 2021 Apr 13; Vol. 6 (16), pp. 10645-10654. Date of Electronic Publication: 2021 Apr 13 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101691658 Publication Model: eCollection Cited Medium: Internet ISSN: 2470-1343 (Electronic) Linking ISSN: 24701343 NLM ISO Abbreviation: ACS Omega Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34056218
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Qian+K%22">Qian K</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.<br /><searchLink fieldCode="AU" term="%22Tang+CY%22">Tang CY</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Changxing People's Hospital of Zhejiang, Huzhou 313100, China.<br /><searchLink fieldCode="AU" term="%22Chen+LY%22">Chen LY</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.<br /><searchLink fieldCode="AU" term="%22Zheng+S%22">Zheng S</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.<br /><searchLink fieldCode="AU" term="%22Ma+LS%22">Ma LS</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China.<br /><searchLink fieldCode="AU" term="%22Fan+LH%22">Fan LH</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Yu+JD%22">Yu JD</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Tan+HS%22">Tan HS</searchLink>; Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.<br /><searchLink fieldCode="AU" term="%22Sun+YL%22">Sun YL</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Shen+LL%22">Shen LL</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill 27599, North Carolina, United States.<br /><searchLink fieldCode="AU" term="%22Xiong+Y%22">Xiong Y</searchLink>; Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.; Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101691658%22">ACS omega</searchLink> [ACS Omega] 2021 Apr 13; Vol. 6 (16), pp. 10645-10654. <i>Date of Electronic Publication: </i>2021 Apr 13 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101691658 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2470-1343 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224701343%22">24701343 </searchLink><i>NLM ISO Abbreviation: </i>ACS Omega <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34056218
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsomega.0c06288
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10645
    Titles:
      – TitleFull: Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Qian K
      – PersonEntity:
          Name:
            NameFull: Tang CY
      – PersonEntity:
          Name:
            NameFull: Chen LY
      – PersonEntity:
          Name:
            NameFull: Zheng S
      – PersonEntity:
          Name:
            NameFull: Zhao Y
      – PersonEntity:
          Name:
            NameFull: Ma LS
      – PersonEntity:
          Name:
            NameFull: Xu L
      – PersonEntity:
          Name:
            NameFull: Fan LH
      – PersonEntity:
          Name:
            NameFull: Yu JD
      – PersonEntity:
          Name:
            NameFull: Tan HS
      – PersonEntity:
          Name:
            NameFull: Sun YL
      – PersonEntity:
          Name:
            NameFull: Shen LL
      – PersonEntity:
          Name:
            NameFull: Lu Y
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Xiong Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 04
              Text: 2021 Apr 13
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2470-1343
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: ACS omega
              Type: main
ResultId 1